Friday Pop Quiz 3/21/2025
A 15-year-old girl who recently moved from India to the United States presents to dermatology clinic with chief concern of the pictured rash. She has previously undergone treatment with 4 weeks of daily terbinafine, as well as 6 weeks of fluconazole, without resolution. KOH reveals numerous branching hyphae.
Which of the following is the most appropriate next step?
A. Initiate topica …
A 15-year-old girl who recently moved from India to the United States presents to dermatology clinic with chief concern of the pictured rash. She has previously undergone treatment with 4 weeks of daily terbinafine, as well as 6 weeks of fluconazole, without resolution. KOH reveals numerous branching hyphae.
Which of the following is the most appropriate next step?
A. Initiate topica … 
Nail disorders can be very troubling for patients. From onycholysis to paronychia to ingrown nails, dermatology clinicians can see a variety of common nail disorders in their patients. So what are some tried and true ways to treat nail disorders? Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Molly Hinshaw, professor of dermatology, … 
The October 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on atopic dermatitis and features mix of original articles, letters to the editor, and case reports. Among many of the topics explored in this issue are statins for treating actinic porokeratosis, ant venom-based ceramide therapy, the psychosocial burden of skin disease among skin of color consumers, treatment of lichen pl … 
Pediatric dermatologic emergencies are very real, highlights Dr. Kalyani Marathe, Associate Professor of Dermatology and Pediatrics at the University of Cincinnati, who lectured during ODAC 2023. Pediatric dermatologic emergencies represent almost 4% of emergency room visits, and of those, most are related to chronic skin disease, drug eruptions, and infections. Here, we will review some of those … 
Psoriasis, a chronic inflammatory skin condition, affects about 2% of children. A small subset have isolated nail involvement refractory to topical treatment that can be disabling. The development of targeted biologic agents offers safe, effective options for children with moderate-to-severe skin and nail disease. A few are now Food and Drug Administration (FDA)-approved for children.
INTRODUCTIO … 